A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyNathalie Goemans, Yasuhiro Takeshima, John E. Kraus et al.|Neuromuscular Disorders|2017Cited by 128
Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectivesAbelardo Araújo, Edmar Zanoteli, Alzira Alves Siqueira Carvalho et al.|Arquivos de Neuro-Psiquiatria|2017Cited by 38
Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectivesAbelardo Araújo, Edmar Zanoteli, Alzira Alves Siqueira Carvalho et al.|LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)|2022Cited by 0